Menu
Back to User profile » Mr Wooseong Kim
Papers published by Mr Wooseong Kim:
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
Yang Y, Kim W, Kim D, Jeong S, Yoo JW, Jung Y
Drug Design, Development and Therapy 2019, 13:231-242
Published Date: 28 December 2018
Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes
Kim W, Yang Y, Kim D, Jeong S, Yoo J, Yoon JH, Jung Y
Drug Design, Development and Therapy 2017, 11:419-429
Published Date: 14 February 2017
Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
Lee S, Lee Y, Kim W, Nam J, Jeong S, Yoo JW, Kim MS, Moon HR, Jung Y
Drug Design, Development and Therapy 2015, 9:4227-4237
Published Date: 7 August 2015
Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement
Yum S, Jeong S, Lee S, Nam J, Kim W, Yoo JW, Kim MS, Lee BL, Jung Y
Drug Design, Development and Therapy 2015, 9:4247-4258
Published Date: 4 August 2015
Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
Lee Y, Kim J, Kim W, Nam J, Jeong S, Lee S, Yoo JW, Kim MS, Jung Y
Drug Design, Development and Therapy 2015, 9:4105-4113
Published Date: 30 July 2015
Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles
Naeem M, Cao J, Choi M, Kim WS, Moon HR, Lee BL, Kim MS, Jung Y, Yoo JW
International Journal of Nanomedicine 2015, 10:4565-4580
Published Date: 16 July 2015